$10.77
-0.21[-1.91%]
At close: Apr 24
$10.77
0[0.00%]
After Hours: 4:00PM EDT
Biomea Fusion
(NASDAQ:BMEA)Latest News for Biomea Fusion Stock (NASDAQ:BMEA)
Biomea Fusion Stock (NASDAQ: BMEA)
Categories: All
Wednesday, April 03, 2024
Tuesday, April 02, 2024
- Biomea Fusion shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $51 to $14.Benzinga Newsdesk - Apr 2, 2024, 10:54AM
- JP Morgan Downgrades Biomea Fusion to Neutral, Lowers Price Target to $14Benzinga Newsdesk - Apr 2, 2024, 10:22AM
Monday, April 01, 2024
- HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $50 Price TargetBenzinga Newsdesk - Apr 1, 2024, 11:51AM
- Truist Securities Reiterates Buy on Biomea Fusion, Maintains $55 Price TargetBenzinga Newsdesk - Apr 1, 2024, 10:25AM
- Biomea Fusion Q4 EPS $(0.98) Misses $(0.85) EstimateBenzinga Newsdesk - Apr 1, 2024, 10:04AM
- Recap: Biomea Fusion Q4 EarningsBenzinga Insights - Apr 1, 2024, 9:50AM
- Biomea Fusion Highlights Initial Data From The First Two Type 1 Diabetes Patients Dosed With BMF-219Benzinga Newsdesk - Apr 1, 2024, 9:04AM
Wednesday, March 06, 2024
- HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $50 Price TargetBenzinga Newsdesk - Mar 6, 2024, 11:58AM
- Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219's 28-Day Treatment Cycle, Supporting Improved Pancreatic FunctionBenzinga Newsdesk - Mar 6, 2024, 3:06AM
Tuesday, February 06, 2024
Thursday, January 25, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
Wednesday, January 03, 2024
Tuesday, December 12, 2023
Monday, December 11, 2023
- Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Dec 11, 2023, 1:12PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Dec 11, 2023, 12:30PM
- What's Going On With Biomea Fusion Stock?Erica Kollmann - Dec 11, 2023, 11:30AM
- Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On MondayAvi Kapoor - Dec 11, 2023, 11:07AM
- Biomea Fusion shares are trading lower after the company announced it presented data for BMF-219 in relapsed / refractory AML patients with menin-dependent mutations at the ASH 2023 Annual Meeting.Benzinga Newsdesk - Dec 11, 2023, 10:09AM
- Biomea Fusion Presents Achievement Of Minimal Residual Disease Negativity In First Complete Responder From Ongoing Phase I Study Of BMF-219 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia At The 2023 ASH Annual MeetingBenzinga Newsdesk - Dec 11, 2023, 9:27AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Dec 11, 2023, 8:06AM
- Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Dec 11, 2023, 7:59AM
Sunday, December 10, 2023
Friday, December 08, 2023
- Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Dec 8, 2023, 12:57PM
- Citigroup Reiterates Buy on Biomea Fusion, Maintains $90 Price TargetBenzinga Newsdesk - Dec 8, 2023, 12:17PM
- Why Is Cancers/Metabolic Diseases-Focused Biomea Fusion Stock Trading Lower Today?Vandana Singh - Dec 8, 2023, 11:47AM
- Biomea Fusion shares are trading lower after the company announced it presented long-term follow-up data from its ongoing Phase II study of BMF-219 in adults with type 2 diabetes in a poster presentation at WCIRDC.Benzinga Newsdesk - Dec 8, 2023, 10:49AM
- Biomea Fusion Presents Long-Term Follow-Up Data Showing Improved Glycemic Control After 22 Weeks Off Treatment In Ongoing Phase II Study Of BMF-219 In Adults With Type 2 Diabetes In Poster Presentation At WCIRDCBenzinga Newsdesk - Dec 8, 2023, 9:06AM
Thursday, December 07, 2023
- Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Dec 7, 2023, 10:17AM
- Biomea Fusion To Present Long-Term Follow-Up Data From Ongoing Phase II Study Of BMF-219 In Adults With Type 2 Diabetes And Results From Ex-Vivo Human Islet Experiments At The World Congress Insulin Resistance, Diabetes & Cardiovascular DiseaseBenzinga Newsdesk - Dec 7, 2023, 9:17AM
Tuesday, December 05, 2023
Monday, December 04, 2023
Wednesday, November 29, 2023
- Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 29, 2023, 2:02PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Nov 29, 2023, 12:31PM
- Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 29, 2023, 8:11AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Nov 29, 2023, 8:06AM